Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer

被引:166
作者
Rabinovich, Brian A. [1 ]
Ye, Yang [1 ]
Etto, Tamara [1 ]
Chen, Jie Qing [1 ]
Levitsky, Hyam I. [2 ]
Overwijk, Willem W. [1 ]
Cooper, Laurence J. N. [1 ]
Gelovani, Juri [1 ]
Hwu, Patrick [1 ]
机构
[1] MD Anderson Canc Ctr, Houston, TX 77054 USA
[2] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
基金
美国国家卫生研究院;
关键词
bioluminescence; immunology; molecular biology;
D O I
10.1073/pnas.0804105105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Antigen specific T cell migration to sites of infection or cancer is critical for an effective immune response. In mouse models of cancer, the number of lymphocytes reaching the tumor is typically only a few hundred, yet technology capable of imaging these cells using bioluminescence has yet to be achieved. A combination of codon optimization, removal of cryptic splice sites and retroviral modification was used to engineer an enhanced firefly luciferase (ffLuc) vector. Compared with ffLuc, T cells expressing our construct-generated > 100 times more light, permitting detection of as few as three cells implanted s.c. while maintaining long term coexpression of a reporter gene (Thy1.1). Expression of enhanced ffLuc in mouse T cells permitted the tracking of < 3 x 10(4) adoptively transferred T cells infiltrating sites of vaccination and preestablished tumors. Penetration of light through deep tissues, including the liver and spleen, was also observed. Finally, we were able to enumerate infiltrating mouse lymphocytes constituting < 0.3% of total tumor cellularity, representing a significant improvement over standard methods of quantitation including flow cytometry.
引用
收藏
页码:14342 / 14346
页数:5
相关论文
共 39 条
[1]   Imaging CD8+ T cell dynamics in vivo using a transgenic luciferase reporter [J].
Azadniv, Mitra ;
Dugger, Kari ;
Bowers, William J. ;
Weaver, Casey ;
Crispe, Ian N. .
INTERNATIONAL IMMUNOLOGY, 2007, 19 (10) :1165-1173
[2]   Murine T cells potently restrict human immunodeficiency virus infection [J].
Baumann, JG ;
Unutmaz, D ;
Miller, MD ;
Breun, SKJ ;
Grill, SM ;
Mirro, J ;
Littman, DR ;
Rein, A ;
KewalRamani, VN .
JOURNAL OF VIROLOGY, 2004, 78 (22) :12537-12547
[3]   NONSPECIFIC CYTO-TOXICITY OF RECOMBINANT INTERLEUKIN-2 ACTIVATED LYMPHOCYTES [J].
BECHARD, DE ;
GUDAS, SA ;
SHOLLEY, MM ;
GRANT, AJ ;
MERCHANT, RE ;
FAIRMAN, RP ;
FOWLER, AA ;
GLAUSER, FL .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1989, 298 (01) :28-33
[4]   In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets [J].
Beilhack, A ;
Schulz, S ;
Baker, J ;
Beilhack, GF ;
Wieland, CB ;
Herman, EI ;
Baker, EM ;
Cao, YA ;
Contag, CH ;
Negrin, RS .
BLOOD, 2005, 106 (03) :1113-1122
[5]   Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice [J].
Breart, Beatrice ;
Lemaitre, Fabrice ;
Celli, Susanna ;
Bousso, Philippe .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (04) :1390-1397
[6]   Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells [J].
Brown, Christine E. ;
Vishwanath, Reena P. ;
Aguilar, Brenda ;
Starr, Renate ;
Najbauer, Joseph ;
Aboody, Karen S. ;
Jensen, Michael C. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (05) :3332-3341
[7]   Photonic detection of bacterial pathogens in living hosts [J].
Contag, CH ;
Contag, PR ;
Mullins, JI ;
Spilman, SD ;
Stevenson, DK ;
Benaron, DA .
MOLECULAR MICROBIOLOGY, 1995, 18 (04) :593-603
[8]   Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit [J].
Costa, GL ;
Sandora, MR ;
Nakajima, A ;
Nguyen, EV ;
Taylor-Edwards, C ;
Slavin, AJ ;
Contag, CH ;
Fathman, CG ;
Benson, JM .
JOURNAL OF IMMUNOLOGY, 2001, 167 (04) :2379-2387
[9]   In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes - Results of a double gene marking trial [J].
Economou, JS ;
Belldegrun, AS ;
Glaspy, J ;
Toloza, EM ;
Figlin, R ;
Hobbs, J ;
Meldon, N ;
Kaboo, R ;
Tso, CL ;
Miller, A ;
Lau, R ;
McBride, W ;
Moen, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) :515-521
[10]   CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation [J].
Edinger, M ;
Hoffmann, P ;
Ermann, J ;
Drago, K ;
Fathman, CG ;
Strober, S ;
Negrin, RS .
NATURE MEDICINE, 2003, 9 (09) :1144-1150